박사

In vivo activity of an anti-virulence agent CC-62520 against Acinetobacter baumannii : Acinetobacter baumannii에 작용하는 항병원성약물 CC-62520의 생체 내 효과

나석현 2020년
논문상세정보
' In vivo activity of an anti-virulence agent CC-62520 against Acinetobacter baumannii : Acinetobacter baumannii에 작용하는 항병원성약물 CC-62520의 생체 내 효과' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의료과학 약
  • acinetobacter baumannii
  • anti-virulence
  • antimicrobial resistance
  • ompA
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
4,041 0

0.0%

' In vivo activity of an anti-virulence agent CC-62520 against Acinetobacter baumannii : Acinetobacter baumannii에 작용하는 항병원성약물 CC-62520의 생체 내 효과' 의 참고문헌

  • molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii
    5 ( [2019]
  • [6] A. Michalopoulos, M.E. Falagas, Treatment of Acinetobacter infections, Expert. Opin. Pharmacother. 11 (2010) 779-88.
  • [3] G. Tillotson, A crucial list of pathogens, Lancet Infect. Dis. 18 (2018) 234-236.
  • [35] G.N. Selasi, A. Nicholas, H. Jeon, S.H. Na, H.I. Kwon, Y.J. Kim, S.T. Heo, M.H. Oh, J.C. Lee, Differences in biofilm mass, expression of biofilm-associated genes, and resistance to desiccation between epidemic and sporadic clones of carbapenem-resistant Acinetobacter baumannii sequence type 191. PLoS One 11 (2016) e0162576.
  • [28] S.W. Kim, C.H. Choi, D.C. Moon, J.S. Jin, J.H. Lee, J.H. Shin, J.M. Kim, Y.C. Lee, S.Y. Seol, D.T. Cho, J.C. Lee, Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins, FEMS Microbiol. Lett. 301 (2009) 224?231.
  • [20] O.M. El-Halfawy, T.L. Czarny, R.S. Flannagan, J. Day, J.C. Jr. Bozelli, R.C. Kuiack, A. Salim, P. Eckert, R.M. Epand, M.J. McGavin, M.G. Organ, D.E. Heinrichs, E.D. Brown, Discovery of an antivirulence compound that reverses ет-lactam resistance in MRSA, Nat. Chem. Biol. (2019) In Press.
  • [15] H. Jeon, S. Kim, M.H. Kim, S.Y. Kim, D. Nam, S.C. Park, S.H. Park, H. Bae, H.J. Lee, J.H. Cho, W.K. Lee, Y.C. Lee, S.H. Lee, M.S. Shin, J.C. Lee. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates from a Korean hospital that carry blaOXA-23. Infect. Genet. Evol. 58 (2018) 232-236.
  • [14] E.J. Yoon, D. Kim, H. Lee, H.S. Lee, J.H. Shin, Y. Uh, K.S. Shin, Y.A. Kim, Y.S. Park, J.H. Shin, S.H. Jeong, Counter Clinical Prognoses of Patients With Bloodstream Infections Between Causative Acinetobacter baumannii Clones ST191 and ST451 Belonging to the International Clonal Lineage II, Front. Public Health 7 (2019) 233.
  • Will 10 million people die a year due to antimicrobial resistance by 2050 ?
    13 ( [2016]
  • Virstatin inhibits dimerization of the transcriptional activator ToxT .
    104 ( [2007]
  • Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii
    14 ( [2014]
  • Using luciferase to image bacterial infections in mice
    48 ( [2011]
  • The race between drug introduction and appearance of microbial resistance
    48 ( [2019]
  • The opportunistic human pathogen Acinetobacter baumannii senses and responds to light
    192 ( [2010]
  • The Old and the New Antibiotics for MDR Gram-Negative Pathogens : For Whom , When , and How
    7 ( [2019]
  • Targeting Innovation in Antibiotic Drug Discovery and Development : The Need for a One Health ? One Europe ? One World Framework , Copenhagen ( Denmark ) : European Observatory on Health Systems and Policies
    https : //www.ncbi.nlm.nih.gov/books/NBK447337/ [2016]
  • Small-molecule inhibitor of VibrioCholera virulence and intestinalColonization ,
    310 ( [2005]
  • Simple method for markerless gene deletion in multidrug-resistant Acinetobacter baumannii
    81 ( [2015]
  • Role of LuxIR homologue AnoIR in Acinetobacter nosocomialis and the effect of virstatin on the expression of anoR gene ,
    25 ( [2015]
  • Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells ,
    7 ( [2005]
  • New treatments of multidrug-resistant Gram-negative ventilator-associated pneumonia
    0.54375 [2018]
  • Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice
    75 ( [2007]
  • Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrugresistant Acinetobacter baumannii
    96 ( [2016]
  • LuxCDE-luxAB-based promoter reporter system to monitor the Yersinia enterocolitica O:3 gene expression in vivo
    12 ( [2017]
  • K2 Capsule depolymerase is highly stable , is refractory to resistance , and protects larvae and mice from Acinetobacter baumannii sepsis
    85 ( [2019]
  • J.M . Cisneros , H. Seifert ; MagicBullet Working Group WP4 , High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece , Italy and Spain as part of. Chemother .
    MagicBullet clinical trial ,
  • Influence of cultural conditions and mutations on the composition of the outer membrane proteins of Escherichia coli
    147 ( [1976]
  • Infection control programs and antibiotic control programs to limit transmission of multi-drug resistant Acinetobacter baumannii infections : evolution of old problems and new challenges for institutes
    12 ( [2015]
  • Increases in mortality , length of stay , and cost associated with hospital-acquired infections in trauma patients
    146 ( [2011]
  • High-throughput screening of small molecules exhibiting potent antimicrobial activity and anti-virulence activity against multi-drug resistant Acinetobacter baumannii strains .
    [2016]
  • Global Challenge of Multidrug-Resistant Acinetobacter baumannii
    51 ( [2007]
  • Genetic basis of resistance to aminoglycosides in Acinetobacter spp . and spread of armA in Acineobacter bauamnnii sequence group 1 in Korean hospital ,
    64 ( [2009]
  • Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract ,
    104 ( 2007 ) 16669 ? 16674
  • Evaluation of biophotonic imaging to estimate bacterial burden in mice infected with highly virulent compared to less virulent Streptococcus pneumoniae serotypes ,
    54 ( [2010]
  • Different drugs for bad bugs : antivirulence strategies in the age of antibiotic resistance ,
    16 ( [2017]
  • Detection of pan drug-resistant Acinetobacter baumannii in Germany , J. Antimicrob
    Chemother69 ( [2014]
  • Carmeli , M. Ouellette , K. Outterson , J. Patel , M. Cavaleri , E.M. Cox , C.R . Houchens , M.L . Grayson , P.
    Theuretzbacher ,
  • Antivirulece as a new antibacterial approach for chemotherapy
    12 ( [2008]
  • Anti-virulence strategies to combat bacteria-mediated disease
    9 ( [2010]
  • Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles
    6 ( [2011]
  • Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins
    8 ( [2013]
  • Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells
    8 ( [2008]
  • A Broad Host Range Mobilization System for In vivo Genetic-Engineering - Transposon Mutagenesis in Gram Negative Bacteria
    1 ( [1983]